Page 1 of Clinical Trials for ambrisentan, 38 Total Matches
- 1Active, not recruitingLast Updated: June 21, 2010Condition(s): Ischemia
- 2RecruitingLast Updated: January 4, 2010Condition(s): Pulmonary Arterial Hypertension; Systemic Sclerosis; Scleroderma Spectrum of Diseases; Connective Tissue Disease; Pulmonary Hypertension
- 3Enrolling by invitationLast Updated: May 5, 2009Condition(s): Pulmonary Hypertension
- 4RecruitingLast Updated: March 5, 2012Condition(s): High Altitude Pulmonary Hypertension
- 5Active, not recruitingLast Updated: March 4, 2010Condition(s): Pulmonary Arterial Hypertension
- 6CompletedLast Updated: December 21, 2011Condition(s): Pulmonary Hypertension
- 7RecruitingLast Updated: June 30, 2011Condition(s): Portopulmonary Hypertension
- 8RecruitingLast Updated: December 8, 2011Condition(s): Hypertension, Pulmonary
- 9RecruitingLast Updated: March 24, 2010Condition(s): Systemic Sclerosis; Scleroderma
- 10RecruitingLast Updated: February 25, 2009Condition(s): Sarcoidosis; Pulmonary Hypertension
- 11TerminatedLast Updated: January 11, 2011Condition(s): Idiopathic Pulmonary Fibrosis; Pulmonary Hypertension
- 12TerminatedLast Updated: December 24, 2010Condition(s): Idiopathic Pulmonary Fibrosis
- 13Active, not recruitingLast Updated: August 11, 2011Condition(s): Hypertension, Pulmonary
- 14CompletedLast Updated: March 20, 2012Condition(s): Pulmonary Arterial Hypertension
- 15CompletedLast Updated: December 15, 2009Condition(s): Pulmonary Hypertension
- 16RecruitingLast Updated: March 15, 2011Condition(s): Pulmonary Hypertension; Heart Failure With Preserved Ejection Fraction
- 17RecruitingLast Updated: April 19, 2012Condition(s): Hypertension, Pulmonary
- 18RecruitingLast Updated: May 10, 2012Condition(s): Hypertension, Pulmonary
- 19CompletedLast Updated: April 2, 2012Condition(s): Pulmonary Hypertension
- 20RecruitingLast Updated: May 17, 2012Condition(s): Exercised Induced Pulmonary Arterial Hypertension; Diastolic Dysfunction
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=ambrisentan
